ASCO 2026: Key Highlights for Stomach/Gastric Cancer Patients
%20(1920%20x%201080%20px).png)
This on‑demand webinar, originally aired June 9, 2026 (6 PM–7 PM CDT), brings together world‑renowned oncologists and a patient advocate to translate complex research into clear, actionable insights for patients, caregivers, and clinicians.
👩⚕️ Expert Panel
- Dr. Yelena Janjigian – Memorial Sloan Kettering Cancer Center
- Dr. Samuel Klempner – Harvard Medical School
- Dr. Elena Elimova – Princess Margaret Cancer Centre
- Frank Blandon – Patient Advocate
🔬 What You’ll Learn
- Top new data and clinical developments from ASCO 2026 in gastric and GEJ cancers
- How these findings impact current and future treatment decisions
- Updates on HER2‑targeted therapies, immunotherapy combinations, and emerging biomarkers
- Insights into ctDNA testing, minimal residual disease (MRD), and personalized care pathways
- Expert perspectives on side‑effect management, treatment duration, and shared decision‑making
💡 Why Watch
This session delivers patient‑friendly, evidence‑based updates that help you stay informed about the most relevant and potentially practice‑changing advances in gastric cancer care. Whether you’re a patient, caregiver, or healthcare professional, you’ll gain clarity on where the field is heading next.
🤝 Partners
In collaboration with: Debbie’s Dream Foundation, Gastric Cancer Foundation, Hope for Stomach Cancer, My Gut Feeling, No Stomach for Cancer, and Stomach Cancer UK
.jpg)
.png)